Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Cash from Investing Activities (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Cash from Investing Activities for 17 consecutive years, with -$34.9 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 721.53% to -$34.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$108.1 million through Dec 2025, up 72.35% year-over-year, with the annual reading at -$108.1 million for FY2025, 72.35% up from the prior year.
  • Cash from Investing Activities hit -$34.9 million in Q4 2025 for Integra Lifesciences Holdings, down from -$15.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $14.8 million in Q3 2022 to a low of -$322.2 million in Q2 2024.
  • Historically, Cash from Investing Activities has averaged -$40.7 million across 5 years, with a median of -$15.6 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 274.69% in 2022 and later tumbled 1972.28% in 2024.
  • Year by year, Cash from Investing Activities stood at -$27.5 million in 2021, then crashed by 99.45% to -$54.8 million in 2022, then decreased by 4.39% to -$57.2 million in 2023, then skyrocketed by 92.58% to -$4.2 million in 2024, then crashed by 721.53% to -$34.9 million in 2025.
  • Business Quant data shows Cash from Investing Activities for IART at -$34.9 million in Q4 2025, -$15.6 million in Q3 2025, and -$21.6 million in Q2 2025.